Trial Profile
A phase I study of AB-001
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs AB 001 (Primary)
- Indications Back pain
- Focus Adverse reactions; Pharmacokinetics
- 24 Jun 2016 New trial record
- 22 Jun 2016 Results published in a Frontier Biotechnologies media release.